Relapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated with or without Rituximab

Background  Autoimmune thrombotic thrombocytopenic purpura (iTTP) is caused by autoantibody-mediated severe a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13 (ADAMTS13) deficiency leading to micro-angiopathic haemolytic anaemia (MAHA) and thrombocytopenia with organ dam...

Descripción completa

Detalles Bibliográficos
Autores principales: Falter, Tanja, Herold, Stephanie, Weyer-Elberich, Veronika, Scheiner, Carina, Schmitt, Veronique, von Auer, Charis, Messmer, Xavier, Wild, Philipp, Lackner, Karl J., Lämmle, Bernhard, Scharrer, Inge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202932/
https://www.ncbi.nlm.nih.gov/pubmed/30235478
http://dx.doi.org/10.1055/s-0038-1668545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202932/
https://www.ncbi.nlm.nih.gov/pubmed/30235478
http://dx.doi.org/10.1055/s-0038-1668545

Ejemplares similares